BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,741 | -99.9% | 85,400 | +24.9% | 0.01% | 0.0% |
| Q1 2022 | $4,369,000 | -67.4% | 68,400 | -55.1% | 0.01% | -70.6% |
| Q2 2021 | $13,403,000 | -30.9% | 152,374 | -23.6% | 0.02% | -29.2% |
| Q1 2021 | $19,388,000 | -38.7% | 199,400 | -29.3% | 0.02% | -29.4% |
| Q4 2020 | $31,615,000 | +84.2% | 281,900 | +52.2% | 0.03% | +100.0% |
| Q3 2020 | $17,168,000 | +268.6% | 185,200 | +210.2% | 0.02% | +325.0% |
| Q2 2020 | $4,657,000 | -27.1% | 59,700 | -45.3% | 0.00% | -33.3% |
| Q1 2020 | $6,386,000 | -59.1% | 109,200 | -55.6% | 0.01% | -33.3% |
| Q2 2018 | $15,603,000 | +2267.7% | 245,800 | +1790.8% | 0.01% | +800.0% |
| Q2 2017 | $659,000 | -55.9% | 13,000 | -65.2% | 0.00% | -50.0% |
| Q1 2017 | $1,496,000 | +407.1% | 37,400 | +256.2% | 0.00% | – |
| Q4 2016 | $295,000 | -11.4% | 10,500 | -6.2% | 0.00% | -100.0% |
| Q3 2016 | $333,000 | – | 11,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
| DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
| Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
| Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
| CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
| Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
| Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
| Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
| Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
| EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |